PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Certain biomarkers appear to increase risk of death for elderly patients with heart failure symptoms

2011-05-25
(Press-News.org) Elderly patients with symptoms of heart failure and increased concentrations in the blood of the biomarker copeptin, or a combination of elevated concentrations of copeptin and the biomarker NT-proBNP, had an associated increased risk of all-cause death, according to a study in the May 25 issue of JAMA.

"A central part in evaluation of elderly patients with symptoms of heart failure is to identify simple tools that can aid the clinician in identifying high-risk and low-risk patients. Combining a biomarker produced locally in the myocardium [the muscle tissue of the heart] with a marker produced centrally in the body may be useful in patients with symptoms of heart failure. Studies have consequently tried to establish the clinical use of different markers in the circulation," the authors write.

One such established marker is B-type natriuretic peptide and the N-terminal fragment of its precursor (NT-proBNP). Vasopressin is a non-cardiac plasma marker of cardiovascular disease. The plasma concentration of vasopressin increases in patients with heart failure and is associated with left ventricular dysfunction. Copeptin has emerged as a potential surrogate marker for measurement of vasopressin concentration and may help identify patients with heart failure at high and low risk of death, according to background information in the article.

Urban Alehagen, M.D., Ph.D., of Linkoping University, Linkoping, Sweden and colleagues evaluated the association of combined measurement of plasma copeptin and NT-proBNP concentrations with mortality in an elderly primary care population with symptoms of heart failure. The study included 470 elderly patients in Sweden with heart failure symptoms between January and December 1996. Clinical examination, echocardiography, and measurement of peptide concentrations were performed, with follow-up through December 2009.

During a median (midpoint) follow-up of 13 years, there were 226 deaths from all causes, including 146 cardiovascular deaths. The mortality distribution across the different measures of copeptin segmented into quartiles (fourths) ranged from 26.5 percent (first quartile) to 46.6 percent (fourth quartile) for cardiovascular mortality and from 38.5 percent (first quartile) to 69.5 percent (fourth quartile) for all-cause mortality. The corresponding distribution for NT-proBNP was 15.9 percent (first quartile) to 56.9 percent (fourth quartile) for cardiovascular mortality and between 28.3 percent (first quartile) to 75.9 percent (fourth quartile) for all-cause mortality.

In models comparing the second, third, and fourth quartiles against the first quartile of the biomarkers, concentrations of copeptin and NT-proBNP were associated with long-term all-cause mortality, both separately and in combination. Similar results were obtained in models examining cardiovascular mortality. Analysis of data showed all-cause mortality associated with different combinations of copeptin and NT-proBNP, from a group with low plasma concentrations of both markers (group 1, with 63.7 percent survival) to a group with a combination of high plasma concentrations of both markers (group 4, with 16.5 percent survival). Prognostic information obtained by the markers was greater when both were combined.

"The objective of this study was to apply markers in a patient group commonly encountered in primary care, i.e., elderly patients who often present with other diseases, making interpretation of symptoms difficult. The original design of our cohort study did not allow us to assess diagnostic elements of biomarker measurement. Instead, we focused solely on the prognostic information of the markers when applied in a primary care population. These data, together with our findings of the prognostic information provided by measurement of copeptin concentrations in elderly patients with symptoms of heart failure, suggest that vasopressin may be a potential target for therapeutic intervention."

###

(JAMA. 2011;305[20]2088-2095. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

To contact Urban Alehagen, M.D., Ph.D., email urban.alehagen@liu.se.

END



ELSE PRESS RELEASES FROM THIS DATE:

Rethinking extinction risk?

2011-05-25
For more than 40 years, the International Union for Conservation of Nature (IUCN) has published the Red List of Threatened Species describing the conservation status of various species of animals. They are now also including plants in their lists and the picture they present is dramatic. According to recent estimates, around 20 per cent of flowering plants are currently at risk of extinction – though the exact number is unknown since such a small proportion of plant species has even been measured. Now, however, research conducted in South Africa and the U.K. by an international ...

The healing power of hydrogen peroxide

2011-05-25
New information has come to light explaining how injured skin cells and touch-sensing nerve fibers coordinate their regeneration during wound healing. UCLA researchers Sandra Rieger and Alvaro Sagasti found that a chemical signal released by wounded skin cells promotes the regeneration of sensory fibers, thus helping to ensure that touch sensation is restored to healing skin. They discovered that the reactive oxygen species hydrogen peroxide, which is found at high concentrations at wounds, is a key component of this signal. The study, published on May 24th in the online, ...

Grape Escapes - 6 of the Best Vineyard Cycle Routes

Grape Escapes - 6 of the Best Vineyard Cycle Routes
2011-05-25
Once there, exploring by bike means that you'll often stumble upon the lesser-known vineyards too (we'll point you in the right direction!), and you'll find that owners will welcome you as long-lost friends rather than fleeting tourists! Don't forget too that, if you have your car in the region with you, we offer a complimentary wine service where we'll collect any purchases and deliver them to your final hotel for you. So, if you enjoy wine, and fancy the idea of trying out old favourites, as well as making some new discoveries, here are 6 cycling holidays we think ...

Expanded VLA flexing new scientific muscle

2011-05-25
A new and uniquely powerful tool for cutting-edge science is emerging on the crisp, high desert of western New Mexico. Outwardly, it looks much the same as the famed Very Large Array (VLA), a radio telescope that has spent more than three decades on the frontiers of astronomical research. The 27 white, 230-ton dish antennas still peer skyward, the 72 miles of railroad track still wait to transport the antennas across the arid plains, the familiar buildings remain, and crews still fan out across the desert to service the antennas. Functionally, however, everything has ...

Research suggests that lipofilling may be safe during conservation treatment for breast cancer

2011-05-25
A new study has gone some way to answering the question about whether or not a technique called lipofilling is safe for women who are having their breasts reconstructed after surgery for breast cancer. Lipofilling involves taking some fat from another area of a woman's body, such as her abdomen, and using it to fill in small defects or asymmetry that may occur during breast reconstruction. However, until now, there has been a lack of evidence as to whether or not the technique could trigger a recurrence of the original breast cancer, and so plastic surgeons have not ...

Atrial fibrillation associated with increased risk of death and cardiovascular events in women

2011-05-25
Boston, MA – Researchers at Brigham and Women's Hospital (BWH) have found that among women who are mostly healthy, those diagnosed with atrial fibrillation have an increased risk of death when compared to women without atrial fibrillation. These findings are published in the May 25, 2011 issue of the Journal of the American Medical Association. "We knew that atrial fibrillation was associated with an increase risk of death in most cases, but in this study we found that even in a population of women who were mostly healthy and did not have established cardiovascular ...

Wales faces deepest NHS cuts of all UK countries

2011-05-25
In Wales, the NHS is set for a real budget cut of nearly 11% over four years, while England escapes the deepest cuts across the four nations, according to John Appleby, Chief Economist at the King's Fund on bmj.com today. In much of the discussion and debate about health care spending and reform, the "N" in NHS seems often to stand for England, writes Appleby. Yet around 10 million people in the UK do not live in England or use its health care services. Given the political arguments about whether the NHS budget has received a real increase in funding over the next ...

Increasing daily calcium will not reduce the risk of fractures in later life

2011-05-25
While moderate amounts of calcium (around 700 mg a day) are vital for maintaining healthy bones, there is no need to start increasing calcium intake in order to reduce the risk of fractures or osteoporosis in later life, finds a paper published on bmj.com today. As people age, their bones lose calcium and they are more at risk of fractures and osteoporosis - this is especially the case for women. As well as causing individual suffering, fractures are a huge drain on health services. With ageing populations, this burden will increase in the coming years and therefore ...

Comparable effectiveness shown for 2 common sudden deafness treatments

2011-05-25
Direct injection of steroids into the middle ear for the treatment of sudden deafness was shown to be no more or less effective than oral steroids in restoring hearing levels in a large comparison study of patients. The study results appear in the May 25, 2011 issue of the Journal of the American Medical Association. The multicenter clinical trial was funded by the National Institute on Deafness and Other Communication Disorders (NIDCD), part of the National Institutes of Health. It is the largest treatment trial ever conducted to study the outcomes, over time, of patients ...

Should You Get a Crown or an Implant?

2011-05-25
If one of your teeth has suffered significant damage or decay, your dentist may give you the option of whether you want to put a dental crown on the tooth or if you would like to have the tooth removed and have it replaced with a dental implant. Here are some important things to keep in mind when making this decision. When You Want to Get a Crown In most cases, you and your dentist should work together to preserve a damaged tooth. Although dental implants are good, nothing beats the strength of natural tooth structure. A dental crown allows you to protect and strengthen ...

LAST 30 PRESS RELEASES:

LHAASO uncovers mystery of cosmic ray "knee" formation

The simulated Milky Way: 100 billion stars using 7 million CPU cores

Brain waves’ analog organization of cortex enables cognition and consciousness, MIT professor proposes at SfN

Low-glutamate diet linked to brain changes and migraine relief in veterans with Gulf War Illness

AMP 2025 press materials available

New genetic test targets elusive cause of rare movement disorder

A fast and high-precision satellite-ground synchronization technology in satellite beam hopping communication

What can polymers teach us about curing Alzheimer's disease?

Lead-free alternative discovered for essential electronics component

BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders

Skin cancer cluster found in 15 Pennsylvania counties with or near farmland

For platforms using gig workers, bonuses can be a double-edged sword

Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon

New study reveals key role of inflammasome in male-biased periodontitis

MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer

Donors enable record pool of TPDA Awards to Neuroscience 2025

Society for Neuroscience announces Gold Sponsors of Neuroscience 2025

The world’s oldest RNA extracted from woolly mammoth

Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show

Reading a quantum clock costs more energy than running it, study finds

Early MMR vaccine adoption during the 2025 Texas measles outbreak

Traces of bacteria inside brain tumors may affect tumor behavior

Hypertension affects the brain much earlier than expected

Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio

Drift logs destroying intertidal ecosystems

New test could speed detection of three serious regional fungal infections

New research on AI as a diagnostic tool to be featured at AMP 2025

New test could allow for more accurate Lyme disease diagnosis

New genetic tool reveals chromosome changes linked to pregnancy loss

New research in blood cancer diagnostics to be featured at AMP 2025

[Press-News.org] Certain biomarkers appear to increase risk of death for elderly patients with heart failure symptoms